Founders Capital Management Genmab A/S Transaction History
Founders Capital Management
- $166 Million
- Q2 2025
A detailed history of Founders Capital Management transactions in Genmab A/S stock. As of the latest transaction made, Founders Capital Management holds 1,000 shares of GMAB stock, worth $22,010. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$22,010% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding GMAB
# of Institutions
247Shares Held
66.2MCall Options Held
729KPut Options Held
398K-
Alliancebernstein L.P. New York, NY14.7MShares$324 Million0.11% of portfolio
-
Orbis Allan Gray LTD Hamilton, D05.71MShares$126 Million0.8% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$112 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.43MShares$97.4 Million0.02% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.88MShares$63.4 Million0.45% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $14.5B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...